Skip to main content

Advertisement

SpringerLink
Log in

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. O’Reilly MK, Paulson JC . Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci 2009; 30: 240–248.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bross PF, Beitz J, Chen G, Chen XH, Duffy E, Kieffer L et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res 2001; 7: 1490–1496.

    CAS  PubMed  Google Scholar 

  3. Singer H, Kellner C, Lanig H, Aigner M, Stockmeyer B, Oduncu F et al. Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16. J Immunother 2010; 33: 599–608.

    Article  CAS  PubMed  Google Scholar 

  4. Baeuerle PA, Kufer P, Bargou R . BiTE: Teaching antibodies to engage T-cells for cancer therapy. Curr Opin Mol Ther 2009; 11: 22–30.

    CAS  PubMed  Google Scholar 

  5. von Strandmann EP, Hansen HP, Reiners KS, Schnell R, Borchmann P, Merkert S et al. A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo. Blood 2006; 107: 1955–1962.

    Article  PubMed  Google Scholar 

  6. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T . Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255–260.

    Article  CAS  PubMed  Google Scholar 

  7. Maccalli C, Scaramuzza S, Parmiani G . TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors. Cancer Immunol Immunother 2009; 58: 801–808.

    Article  CAS  PubMed  Google Scholar 

  8. Carmo-Fonseca M, Pfeifer K, Schroder HC, Vaz MF, Fonseca JE, Muller WE et al. Identification of La ribonucleoproteins as a component of interchromatin granules. Exp Cell Res 1989; 185: 73–85.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Barbara Uteß, Christine Gräfe, Heidrun Gebauer, Livia Schulze and Martina Franke for excellent technical assistance.

Author information

Authors and Affiliations

  1. Institute of Immunology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany

    S Stamova, M Cartellieri, A Feldmann, C C Bippes, H Bartsch, R Wehner, M Schmitz, E P Rieber & M Bachmann

  2. Medizinische Klinik und Poliklinik I Universitätsklinikum Dresden, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany

    M von Bonin, M Bornhäuser & G Ehninger

  3. From the Center for Regenerative Therapies Dresden, Technical University Dresden, Dresden, Germany

    M Bachmann

Authors
  1. S Stamova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Cartellieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Feldmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C C Bippes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Wehner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M von Bonin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Bornhäuser
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G Ehninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E P Rieber
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Bachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Bachmann.

Ethics declarations

Competing interests

Drs S Stamova and M Bachmann have applied for patents related to the novel anti-CD33 abs and the novel linker module.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stamova, S., Cartellieri, M., Feldmann, A. et al. Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells. Leukemia 25, 1053–1056 (2011). https://doi.org/10.1038/leu.2011.42

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.42

  • Springer Nature Limited

This article is cited by

Search

Navigation